secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001558370-21-009802
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q2 revenue up 45% to $51.1M, net income $1.3M; raises FY guidance low end
--------------------------------------------------------------------------------

- Q2 revenue $51.1M (+45% YoY); net income $1.3M vs loss of $13.9M; diluted EPS $0.07 vs loss of $0.72.
- Adjusted EBITDA $4.1M vs loss of $0.7M; operating loss narrowed to $0.1M from $8.0M.
- Updated FY2021 revenue guidance: $216.3M–$224.5M (growth 16%–20%), low end raised from prior $215.3M.
- Appointed Eric Pauls as SVP of Sales effective May 1, succeeding Bryan Rishe.
- Restated credit facility with Wells Fargo: $25M revolving with $30M accordion (up to $55M), replacing $10M facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/0001558370-21-009802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/tcmd-20210802x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-009802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer